Nautilus Biotechnology (NAUT) vs Quanterix (QTRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Nautilus Biotechnology (NAUT) has outperformed Quanterix (QTRX) over the past year, gaining 101.8% versus a loss of 46.5%. Over five years, NAUT leads with a -68.1% price change compared with -93.8% for QTRX. Nautilus Biotechnology is the larger company by market cap ($231.6 million vs $151.8 million), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NAUT | QTRX |
|---|---|---|
| Share price | $1.82 | $3.21 |
| Market cap | $231.60M | $151.81M |
| 1-day change | -7.14% | -3.46% |
| YTD return | -6.67% | -49.53% |
| 1-year return | +101.77% | -46.50% |
| 5-year return | -68.13% | -93.79% |
| EPS (TTM) | $-0.45 | $-2.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.31 | $8.77 |
| 52-week low | $0.82 | $2.15 |
| Distance from 52-week high | -57.77% | -63.40% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +110.44% | -6.54% |
| Average volume | 2.66M | 762.14K |
| Shares outstanding | 127.26M | 47.29M |
| Employees | 127 | 450 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NAUT has outperformed QTRX by 148.3 percentage points over the past year.
About Nautilus Biotechnology
NAUT stock →Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis.
Industrials · Biotechnology: Laboratory Analytical Instruments · 127 employees
About Quanterix
QTRX stock →Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Industrials · Biotechnology: Laboratory Analytical Instruments · 450 employees
NAUT vs QTRX FAQ
Which is bigger, Nautilus Biotechnology or Quanterix?
Nautilus Biotechnology (NAUT) is larger, with a market capitalization of $231.60M compared with $151.81M for Quanterix (QTRX).
Which stock has performed better over the past year, NAUT or QTRX?
NAUT returned +101.77% over the past 12 months, compared with -46.50% for QTRX (price return, excluding dividends). Past performance does not predict future results.
Are Nautilus Biotechnology and Quanterix in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.